Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Shire’s results magnified by Baxalta purchase

Country: Ireland

Shire Plc’s financial performance in 2016 reflected the impact of its acquisition of Baxalta Inc, its largest takeover to date, as well as the integration of Dyax Corp, a developer of products for rare diseases which was acquired in 2015.

Read more

Chimeric organs described

Country: United States

Scientists at the Salk Institute in California, US have described a series of experiments in which they were able to integrate stem cells from one species into the early-stage development of another. The research was published in the 26 January 2017 edition of Cell, and raises hopes for transplantation.

Read more

Another Alzheimer’s failure

Country: United States

Read more

Actelion produces sizzling annual results

Country: Switzerland

Read more

Monitoring immuno-oncology

Country: Germany

Read more

New DMD drug approved in US

Country: United States

Read more

Brexit fallout discussed

Country: United Kingdom

Read more

Novo invests €90 million in Evotec

Country: Denmark

Read more

Sanofi positions itself in consumer healthcare

Country: France

Read more

GSK cautions over Advair

Country: United Kingdom

Read more

Lundbeck reports better results with more to come

Country: Denmark

Read more

Prexton raises €29 million in Series B round

Country: Switzerland

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Bringing exhausted T cells back from the brink

T cell exhaustion StephenTurnerFeb2017.pdf

Highlights of the February 2017 MedNous issue

The February 2017 MedNous features:

Latest Mednous cover
  • Research Strategy
    Bringing exhausted T cells
    back from the brink
    By Stephen J. Turner
  • The Inventive Step
    How Keytruda was discovered
    Interview with Dutch scientists
  • Commentary
    Protein scaffolds come of age
    By Alastair Smith
  • Regenerative Medicine
    The challenges of cell therapy manufacture
    By Philip Vanek
  • Company Financing
    Novo A/S becomes strategic shareholder in Evotec
  • Clinical Research
    Another Alzheimer’s drug fails

The latest MedNous journal. Subscribe to download.